Sleeve gastrectomy (SG) is currently the most widely performed operation for treatment of morbid obesity. SG leads to significant weight loss and reduction in weight-related comorbidities. This study aimed to evaluate the effects of laparoscopic sleeve gastrectomy (LSG) on the metabolism of patients with obesity.
Methods:
The cases of patients who underwent LSG were reviewed for preoperative medical history, comorbidities, medications, routine preoperative work-up, perioperative outcomes, and postoperative follow-up at months 1, 3, and 6 and years 1 and 2. Body mass index and excess weight loss decreases, comorbidity status, and medication requirements were evaluated.
Results:
A total of 383 patients who regularly attended their follow-up appointments (76.6%) were analyzed. In the postoperative follow-up of 130 (98.49%) patients with type 2 diabetes (p = 0.001), 107 (89.92%) with hypertension (p = 0.001), 130 (98.49%) with sleep apnea syndrome (p = 0.001), 6 (66.67%) with cardiovascular disease (p = 0.031), 23 (95.83%) with dyslipidemia (p = 0.001), and 41 (82%) with osteoarthritis (p = 0.001), resolution or improvement was observed.
Conclusion:
The short-term results of SG surgery in terms of weight loss and resolution from comorbidities have become one of the surgical options for cases of obesity.
Get full access to this article
View all access options for this article.
References
1.
World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Geneva:. 2000. Technical Report Series no. 894.
2.
ChopraM, DarntonhillL. Tobacco and obesity epidemics: not so different after all?. BMJ, 2004; 328:1558–1560.
3.
BrayGA. Classification and evaluation of the obesities. Med Clin North Am, 1989; 73:161–184.
4.
GibsonRS. Anthropometric Assessment of Body Size. Principles of Nutritional Assessment. New York: Oxford University Press, 1990:259–262.
5.
Van ItallieTB. Health implications of overweight and obesity in the United States. Ann Intern Med, 1985; 103:983–988.
FosterWR, BurtonBT, HubbardVS. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr, 1992; 55:615S.
8.
AtkinsonRL, HubbardVS. Report on the NIH workshop on pharmacologic treatment of obesity. Am J Clin Nutr, 1994; 60:153–156.
9.
RubinoF, SchauerPR, KaplanLM, CummingsDE. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med, 2010; 61:393–341.
10.
RubinoF, KaplanLM, SchauerPR, Cummings DE;Diabetes surgery summit delegates. The diabetes surgery summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg, 2010; 251:399–405.
11.
CummingsDE, CohenRV. Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery. Lancet Diabetes Endocrinol, 2014; 2:175–181.
12.
RenCJ, PattersonE, GagnerM. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg. 2000; 10:514–523.
13.
SatmanI, OmerB, TutuncuY, KalacaS, GedikS, DinccagN, et al.Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol, 2013; 28:169–180.
14.
DumonKR, MurayamaKM. Bariatric surgery outcomes. Surg Clin North Am, 2011; 91:1313–1318.
15.
JonesDB, SchneiderBE, YorgancıK. Morbid Obezitenin Cerrahi Tedavisi. In: Fischer JE, LoGerfo FW, Seeger JM, Callery MP, Clagett GP, Jones DB, Özmen MM, Erbil Y, Dilektasli E, Aksoy M, editors. Mastery of surgery. Ankara: Güneş Tıp Kitapevleri, 2011.
16.
FischerJE, YorgancıK. Morbid Obezite. In: Fischer JE, LoGerfo FW, Seeger JM, Callery MP, Clagett GP, Jones DB, Özmen MM, Erbil Y, Dilektasli E, Aksoy M, editors. Mastery of surgery. Ankara: Güneş Tıp Kitapevleri, 2011:962.
17.
VarelaJE, NguyenNT. Laparoscopic sleeve gastrectomy leads the U.S. utilization of bariatric surgery at academic medical centers. Surg Obes Relat Dis, 2015; 11:987–990.
18.
SekiY, KasamaK. Current status of laparoscopic bariatric surgery. Surg Technol Int, 2010; 20:139–144.
19.
National Institutes of Health Consensus Development Panel. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Ann Intern Med, 1991; 115:956–961.
20.
OriaHE, MooreheadMK. Bariatric analysis and reporting outcome system (BAROS). Obes Surg, 1998; 8:487–499.
21.
OmanaJJ, NguyenSQ, HerronD, KiniS. Comparison of comorbidity resolution and improvement between laparoscopic sleeve gastrectomy and laparoscopic adjustable gastric banding. Surg Endosc, 2010; 24:2513–2517.
22.
D'HondtM, VannesteS, PottelH, DevriendtD, RooyFV, VansteenkisteF. Laparoscopic sleeve gastrectomy as a single-stage procedure for the treatment of morbid obesity and the resulting quality of life, resolution of co-morbidities, food tolerance and 6 years weight loss. Surg Endosc, 2011; 25:2498–2504.
23.
TrastulliS, DesiderioJ, GuarinoS, CirocchiR, ScalercioV, NoyaG, et al.Laparoscopic sleeve gastrectomy compared to other bariatric surgical procedures: a systematic review of randomized trials. Surg Obes Relat Dis, 2013; 9:816–829.
24.
HeneghanHM, NissenS, SchauerPR. Gastrointestinal surgery for obesity and diabetes: weight loss and control of hyperglycemia. Curr Atheroscler Rep, 2012; 14:579–587.
25.
le RouxCW, AylwinSJ, BatterhamRL, BorgCM, CoyleF, PrasadV, et al.Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg, 2006; 243:108–114.
26.
MirasAD, le RouxCW. Mechanisms underlying weight loss after bariatric surgery. Nat Rev Gastroenterol Hepatol, 2013; 10:575–584.
27.
GillRS, BirchDW, ShiX, SharmaAM, KarmaliS. Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis, 2010; 6:707–713.
28.
EidGM, BrethauerS, MattarSG, TitchnerRL, GourashW, SchauerPR. Laparoscopic sleeve gastrectomy for super obese patients. Ann Surg, 2012; 256:262–265.
29.
Moon-HanS, KimWW, OhJH. Results of laparoscopic sleeve gastrectomy (LSG) at year in morbidly obese Korea patients. Obes Surg, 2005; 15:1469–1475.
30.
BraghettoI, CsendesA, LanzariniE, PapapietroK, CárcamoC, MolinaJC. Is laparoscopic sleeve gastrectomy an acceptable primary bariatric procedure in obese patients? Early and 5-year postoperative results. Surg Laparosc Endosc Percutan Tech, 2012; 22:479–486.
31.
NoccaD, KrawczykowskyD, BomansB, NoëlP, PicotMC, BlancPM, et al.A prospective multicenter study of 163 sleeve gastrectomies: results at 1 and 2 years. Obes Surg, 2008; 18:560–565.
32.
HimpensJ, DobbeleirJ, PetersG. Long term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg, 2010; 252:319–324.
LeybaJL, AulestiaSN, LlopisSN. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the treatment of morbid obesity. A prospective study of 117 patients. Obes Surg, 2011; 21:212–216.
35.
LemanuDP, SinghPP, RahmanH, HillAG, BaborR, MacCormickAD. Five-year results after laparoscopic sleeve gastrectomy: a prospective study. Obes Surg, 2015; 11:489–738.
36.
BozaC, DarochD, BarrosD, LeonF, FunkeR, CrovariF. Long-term outcomes of laparoscopic sleeve gastrectomy as a primary bariatric procedure. Surg Obes Relat Dis, 2014; 10:1129–1134.
37.
MarceauP, HouldFS, SimardS, LebelS, BourqueRA, PotvinM, et al.Biliopancreatic diversion with duodenal switch. World J Surg, 1998; 22:947–954.
38.
LeeCM, CiranglePT, JossartGH. Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc, 2007; 21:1810–1816.
